Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Y Di Veroli

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Frontiers in Pharmacology|April 9, 2015
A new classifier-based strategy for in-silico ion-channel cardiac drug safety assessmentHitesh B Mistry, Mark R Davies, Giovanni Y Di Veroli
Journal of Cardiovascular Electrophysiology|October 15, 2013
hERG inhibitors with similar potency but different binding kinetics do not pose the same proarrhythmic risk: implications for drug safety assessmentGiovanni Y DI Veroli, Mark R Davies, Henggui Zhang, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 30, 2012
High-throughput screening of drug-binding dynamics to HERG improves early drug safety assessmentGiovanni Y Di Veroli, Mark R Davies, Henggui Zhang, et al.
Plos Computational Biology|May 4, 2017
Modelling of the cancer cell cycle as a tool for rational drug development: A systems pharmacology approach to cyclotherapyRobert C Jackson, Giovanni Y Di Veroli, Siang-Boon Koh, et al.
Bioinformatics (Oxford, England)|May 7, 2016
Combenefit: an interactive platform for the analysis and visualization of drug combinationsGiovanni Y Di Veroli, Chiara Fornari, Dennis Wang, et al.
Frontiers in Pharmacology|November 13, 2024
Modelling hemodynamics regulation in rats and dogs to facilitate drugs safety risk assessmentChristopher J Morris, Michael G Rolf, Linda Starnes, et al.
Scientific Reports|October 2, 2015
An automated fitting procedure and software for dose-response curves with multiphasic featuresGiovanni Y Di Veroli, Chiara Fornari, Ian Goldlust, et al.
Nature Communications|June 19, 2019
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screenMichael P Menden, Dennis Wang, Mike J Mason, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers in Pharmacology|April 9, 2015
A new classifier-based strategy for in-silico ion-channel cardiac drug safety assessmentHitesh B Mistry, Mark R Davies, Giovanni Y Di Veroli
Journal of Cardiovascular Electrophysiology|October 15, 2013
hERG inhibitors with similar potency but different binding kinetics do not pose the same proarrhythmic risk: implications for drug safety assessmentGiovanni Y DI Veroli, Mark R Davies, Henggui Zhang, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 30, 2012
High-throughput screening of drug-binding dynamics to HERG improves early drug safety assessmentGiovanni Y Di Veroli, Mark R Davies, Henggui Zhang, et al.
Plos Computational Biology|May 4, 2017
Modelling of the cancer cell cycle as a tool for rational drug development: A systems pharmacology approach to cyclotherapyRobert C Jackson, Giovanni Y Di Veroli, Siang-Boon Koh, et al.
Bioinformatics (Oxford, England)|May 7, 2016
Combenefit: an interactive platform for the analysis and visualization of drug combinationsGiovanni Y Di Veroli, Chiara Fornari, Dennis Wang, et al.
Frontiers in Pharmacology|November 13, 2024
Modelling hemodynamics regulation in rats and dogs to facilitate drugs safety risk assessmentChristopher J Morris, Michael G Rolf, Linda Starnes, et al.
Scientific Reports|October 2, 2015
An automated fitting procedure and software for dose-response curves with multiphasic featuresGiovanni Y Di Veroli, Chiara Fornari, Ian Goldlust, et al.
Nature Communications|June 19, 2019
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screenMichael P Menden, Dennis Wang, Mike J Mason, et al.
Pageof 1